Addiction to protein kinase CK2: A common denominator of diverse cancer cells?

Huang, 1996, Ultrasensitivity in the mitogen-activated protein kinase cascade, Proc. Natl. Acad. Sci. USA, 93, 10078, 10.1073/pnas.93.19.10078

Teng, 2001, Mutation analyses of 268 candidate genes in human tumor cell lines, Genomics, 74, 352, 10.1006/geno.2001.6551

Oka, 1996, Deletion of specific protein kinase C subspecies in human melanoma cells, J. Cell. Physiol., 167, 406, 10.1002/(SICI)1097-4652(199606)167:3<406::AID-JCP4>3.0.CO;2-T

WEB site: www.cellsignal.com/reference/kinase_disease.html.

Hopkins, 2002, The druggable genome, Nat. Rev., Drug. Discov., 1, 727, 10.1038/nrd892

Manning, 2002, The protein kinase complement of the human genome, Science, 298, 1912, 10.1126/science.1075762

Multi-Authors Review (C. Gambacorti-Passerini guest-ed.), Oncogenic tyrosine kinases, Cell. Mol. Life. Sci. 61 (2004) 2895–2978.

Druker, 2006, Circumventing resistance to kinase-inhibitor therapy, N. Engl. J. Med., 354, 2594, 10.1056/NEJMe068073

Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9

Pinna, 2002, Protein kinase CK2: a challenge to canons, J. Cell. Sci., 115, 3873, 10.1242/jcs.00074

Litchfield, 2003, Protein kinase CK2: structure, regulation and role in cellular decisions of life and death, Biochem. J., 369, 1, 10.1042/bj20021469

Salvi, 2009, Extraordinary pleiotropy of protein kinase CK2 revealed by weblogo phosphoproteome analysis, Biochim. Biophys. Acta, 1793, 847, 10.1016/j.bbamcr.2009.01.013

Poole, 2005, A global view of CK2 function and regulation, Mol. Cell. Biochem., 274, 163, 10.1007/s11010-005-2945-z

Knight, 2005, Features of selective kinase inhibitors, Chem. Biol., 12, 621, 10.1016/j.chembiol.2005.04.011

Tawfic, 2001, Protein kinase CK2 signal in neoplasia, Histol. Histopathol., 16, 573

Unger, 2004, Protein kinase CK2 as regulator of cell survival: implications for cancer therapy, Curr. Cancer Drug Targets, 4, 77, 10.2174/1568009043481687

Guerra, 2008, Protein kinase CK2 in human diseases, Curr. Med. Chem., 15, 1870, 10.2174/092986708785132933

Duncan, 2008, Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2, Biochim. Biophys. Acta, 1784, 33, 10.1016/j.bbapap.2007.08.017

Sarno, 2008, Protein kinase CK2 as a druggable target, Mol. Biosyst., 4, 889, 10.1039/b805534c

Seldin, 1995, Casein kinase II alpha transgene-induced murine lymphoma: relation to theileriosis in cattle, Science, 267, 894, 10.1126/science.7846532

Channavajhala, 2002, Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesis, Oncogene, 21, 5280, 10.1038/sj.onc.1205640

Miyata, 2004, CK2 controls multiple protein kinases by phosphorylating a kinase-targeting molecular chaperone, Cdc37, Mol. Cell. Biol., 24, 4065, 10.1128/MCB.24.9.4065-4074.2004

Mishra, 2007, Treatment of P190 Bcr/Abl lymphoblastic leukemia cells with inhibitors of the serine/threonine kinase CK2, Leukemia, 21, 178, 10.1038/sj.leu.2404460

Piazza, 2006, Multiple myeloma cell survival relies on high activity of protein kinase CK2, Blood, 108, 1698, 10.1182/blood-2005-11-013672

Di Maira, 2007, Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level, Oncogene, 26, 6915, 10.1038/sj.onc.1210495

Ljubimov, 2004, Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization, Invest. Ophthalmol. Vis. Sci., 45, 4583, 10.1167/iovs.04-0686

Torres, 2001, The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation, J. Biol. Chem., 276, 993, 10.1074/jbc.M009134200

Torres, 2003, Phosphorylation-regulated cleavage of the tumor suppressor PTEN by caspase-3: implications for the control of protein stability and PTEN-protein interactions, J. Biol. Chem., 278, 30652, 10.1074/jbc.M212610200

Guerra, 2006, Protein kinase CK2 subunits are positive regulators of AKT kinase, Int. J. Oncol., 28, 685

Di Maira, 2005, Protein kinase CK2 phosphorylates and upregulates Akt/PKB, Cell Death Differ., 12, 668, 10.1038/sj.cdd.4401604

Di Maira, 2009, Dephosphorylation and inactivation of Akt/PKB is counteracted by protein kinase CK2 in HEK 293T cells, Cell. Mol. Life. Sci., 66, 3363, 10.1007/s00018-009-0108-1

Dominguez, 2009, CK2 and its role in Wnt and NF-kappaB signaling: Linking development and cancer, Cell. Mol. Life. Sci., 66, 1850, 10.1007/s00018-009-9153-z

Chu, 1996, Basal phosphorylation of the PEST domain in the I(kappa)B(beta) regulates its functional interaction with the c-rel proto-oncogene product, Mol. Cell. Biol., 16, 5974, 10.1128/MCB.16.11.5974

McElhinny, 1996, Casein kinase II phosphorylates I kappa B alpha at S-283, S-289, S-293, and T-291 and is required for its degradation, Mol. Cell. Biol., 16, 899, 10.1128/MCB.16.3.899

Eddy, 2005, Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells, Cancer Res., 65, 11375, 10.1158/0008-5472.CAN-05-1602

Wang, 2000, Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II, J. Biol. Chem., 275, 32592, 10.1074/jbc.M001358200

Chantôme, 2004, Casein kinase II-mediated phosphorylation of NF-kappaB p65 subunit enhances inducible nitric-oxide synthase gene transcription in vivo, J. Biol. Chem., 279, 23953, 10.1074/jbc.M313731200

Song, 2000, Endogenous protein kinase CK2 participates in Wnt signaling in mammary epithelial cells, J. Biol. Chem., 275, 23790, 10.1074/jbc.M909107199

Song, 2003, CK2 phosphorylation of the armadillo repeat region of beta-catenin potentiates Wnt signaling, J. Biol. Chem., 278, 24018, 10.1074/jbc.M212260200

Desagher, 2001, Phosphorylation of bid by casein kinase I and II regulates its cleavage by caspase 8, Mol. Cell, 8, 601, 10.1016/S1097-2765(01)00335-5

Krippner-Heidenreich, 2001, Targeting of the transcription factor Max during apoptosis: phosphorylation-regulated cleavage by caspase-5 at an unusual glutamic acid residue in position P1, Biochem. J., 358, 705, 10.1042/0264-6021:3580705

Ruzzene, 2002, Protein kinase CK2 inhibitor 4, 5, 6, 7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells, Biochem. J., 364, 41, 10.1042/bj3640041

Walter, 1999, Phosphorylation of presenilin-2 regulates its cleavage by caspases and retards progression of apoptosis, Proc. Natl. Acad. Sci. USA, 96, 1391, 10.1073/pnas.96.4.1391

Yin, 2001, Regulation of lens connexin 45.6 by apoptotic protease, caspase-3, Cell. Commun. Adhes., 8, 373, 10.3109/15419060109080756

McDonnell, 2008, Phosphorylation of murine caspase-9 by the protein kinase casein kinase 2 regulates its cleavage by caspase-8, J. Biol. Chem., 283, 20149, 10.1074/jbc.M802846200

Li, 2002, Phosphorylation by protein kinase CK2: a signaling switch for the caspase-inhibiting protein ARC, Mol. Cell, 10, 247, 10.1016/S1097-2765(02)00600-7

Ghavidel, 2001, TATA binding protein-associated CK2 transduces DNA damage signals to the RNA polymerase III transcription machinery, Cell, 106, 575, 10.1016/S0092-8674(01)00473-1

Scaglioni, 2006, A CK2-dependent mechanism for degradation of the PML tumor suppressor, Cell, 126, 269, 10.1016/j.cell.2006.05.041

Loizou, 2004, The protein kinase CK2 facilitates repair of chromosomal DNA single-strand breaks, Cell, 117, 17, 10.1016/S0092-8674(04)00206-5

Lou, 2008, The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development, Mol. Cell. Biol., 28, 131, 10.1128/MCB.01119-07

Sale, 2008, Protein kinase B: signalling roles and therapeutic targeting, Cell. Mol. Life Sci., 65, 113, 10.1007/s00018-007-7274-9

Arevalo, 2006, Activation of casein kinase II and inhibition of phosphatase and tensin homologue deleted on chromosome 10 phosphatase by nerve growth factor/p75NTR inhibit glycogen synthase kinase-3beta and stimulate axonal growth, Mol. Biol. Cell, 17, 3369, 10.1091/mbc.E05-12-1144

Silva, 2008, PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability, J. Clin. Invest., 118, 3762, 10.1172/JCI34616

Sato, 2000, Modulation of Akt kinase activity by binding to Hsp90, Proc. Natl. Acad. Sci. USA, 97, 10832, 10.1073/pnas.170276797

Tapia, 2006, Casein kinase 2 (CK2) increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription, Proc. Natl. Acad. Sci. USA, 103, 15079, 10.1073/pnas.0606845103

Meggio, 2003, One-thousand-and-one substrates of protein kinase CK2?, FASEB J., 17, 349, 10.1096/fj.02-0473rev

Pinna, 1990, Casein kinase 2: an ‘eminence grise’ in cellular regulation?, Biochim. Biophys. Acta, 1054, 267, 10.1016/0167-4889(90)90098-X

St-Denis, 2009, From birth to death: the role of protein kinase CK2 in the regulation of cell proliferation and survival, Cell. Mol. Life. Sci., 66, 1817, 10.1007/s00018-009-9150-2

Weinstein, 2002, Cancer. Addiction to oncogenes—the Achilles heal of cancer, Science, 297, 63, 10.1126/science.1073096

Solimini, 2007, Non-oncogene addiction and the stress phenotype of cancer cells, Cell, 130, 986, 10.1016/j.cell.2007.09.007

Vadas, 2008, The role of sphingosine kinase 1 in cancer: oncogene or non-oncogene addiction?, Biochim. Biophys. Acta, 1781, 442, 10.1016/j.bbalip.2008.06.007

Allende-Vega, 2005, Phosphorylation of the acidic domain of Mdm2 by protein kinase CK2, Mol. Cell. Biochem., 274, 85, 10.1007/s11010-005-3074-4

Belguise, 2007, Green tea polyphenols reverse cooperation between c-Rel and CK2 that induces the aryl hydrocarbon receptor, slug, and an invasive phenotype, Cancer Res., 67, 11742, 10.1158/0008-5472.CAN-07-2730

Timofeeva, 2006, Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis, Oncogene, 25, 7555, 10.1038/sj.onc.1209742

Bohana-Kashtan, 2005, Extracellular phosphorylation of C9 by protein kinase CK2 regulates complement-mediated lysis, Eur. J. Immunol., 35, 1939, 10.1002/eji.200425716

Kim, 2007, Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia, Clin. Cancer Res., 13, 1019, 10.1158/1078-0432.CCR-06-1602

Cozza, 2006, Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening application, J. Med. Chem., 49, 2363, 10.1021/jm060112m

Di Maira, 2008, Comparative analysis of CK2 expression and function in tumor cell lines displaying sensitivity vs. resistance to chemical induced apoptosis, Mol. Cell. Biochem., 316, 155, 10.1007/s11010-008-9813-6

Hessenauer, 2003, Inhibition of CK2 activity provokes different responses in hormone-sensitive and hormone-refractory prostate cancer cells, Int. J. Oncol., 22, 1263

Sandholt, 2009, Resorufin: a lead for a new protein kinase CK2 inhibitor, Anticancer Drugs, 20, 238, 10.1097/CAD.0b013e328326472e

Wang, 2008, Impact of protein kinase CK2 on inhibitor of apoptosis proteins in prostate cancer cells, Mol. Cell. Biochem., 316, 91, 10.1007/s11010-008-9810-9

Ravi, 2002, Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II, Cancer Res., 62, 4180

Farah, 2003, 5, 6-Dichloro-ribifuranosylbenzimidazole- and apigenin-induced sensitization of colon cancer cells to TNF-alpha-mediated apoptosis, Am. J. Physiol., Gastrointest. Liver Physiol., 285, G919, 10.1152/ajpgi.00205.2003

Izeradjene, 2005, Casein kinase II (CK2) enhances death-inducing signaling complex (DISC) activity in TRAIL-induced apoptosis in human colon carcinoma cell lines, Oncogene, 24, 2050, 10.1038/sj.onc.1208397

Kim, 2008, Inhibition of casein kinase 2 enhances the death ligand- and natural kiler cell-induced hepatocellular carcinoma cell death, Clin. Exp. Immunol., 152, 336, 10.1111/j.1365-2249.2008.03622.x

Llobet, 2008, CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells, Oncogene, 27, 2513, 10.1038/sj.onc.1210924

Izeradjene, 2004, Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells, Clin. Cancer Res., 10, 6650, 10.1158/1078-0432.CCR-04-0576

Hamacher, 2007, Casein kinase II inhibition induces apoptosis in pancreatic cancer cells, Oncol. Rep., 18, 695

Romieu-Mourez, 2002, Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells, Cancer Res., 62, 6770

Yde, 2007, Induction of cell death in antiestrogen resistant human breast cancer cells by the protein kinase CK2 inhibitor DMAT, Cancer Lett., 256, 229, 10.1016/j.canlet.2007.06.010

Prudent, 2008, Expanding the chemical diversity of CK2 inhibitors, Mol. Cell. Biochem., 316, 71, 10.1007/s11010-008-9828-z

Wang, 2005, Downregulation of CK2 induces apoptosis in cancer cells—a potential approach to cancer therapy, Mol. Cell. Biochem., 274, 77, 10.1007/s11010-005-3077-1

Pagano, 2008, The selectivity of inhibitors of protein kinase CK2: an update, Biochem. J., 415, 353, 10.1042/BJ20080309